XBI vs. FLIN

Last updated Jun 12, 2026

XBI (SPDR S&P Biotech ETF) and FLIN (Franklin FTSE India ETF) are both exchange-traded funds - XBI is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index, while FLIN is a Asia Pacific Equities fund tracking the FTSE India RIC Capped Index. Both are passively managed. Over the past 5 years, XBI returned -0.35%/yr vs 3.66%/yr for FLIN. At a 0.35 correlation, their price movements are largely independent. XBI charges 0.35%/yr vs 0.19%/yr for FLIN.

Performance

XBI vs. FLIN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SPDR S&P Biotech ETF (XBI) and Franklin FTSE India ETF (FLIN). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, XBI achieves a 8.87% return, which is significantly higher than FLIN's -11.27% return.

XBI

• 1D: 3.02%
• 1M: -1.61%
• YTD: 8.87%
• 6M: 8.26%
• 1Y: 57.91%
• 3Y*: 14.63%
• 5Y*: -0.35%
• 10Y*: 9.42%

FLIN

• 1D: 0.88%
• 1M: 0.50%
• YTD: -11.27%
• 6M: -10.27%
• 1Y: -13.20%
• 3Y*: 5.71%
• 5Y*: 3.66%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

XBI vs. FLIN - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018
XBI SPDR S&P Biotech ETF	8.87%	35.89%	1.01%	7.60%	-25.87%	-20.45%	48.33%	32.56%	-21.35%
FLIN Franklin FTSE India ETF	-11.27%	2.40%	10.33%	20.58%	-7.96%	24.96%	14.50%	4.77%	-7.13%

Correlation

The correlation between XBI and FLIN is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.34
Correlation (3Y) Calculated over the trailing 3-year period	0.35
Correlation (5Y) Calculated over the trailing 5-year period	0.37
Correlation (All Time) Calculated using the full available price history since Feb 8, 2018	0.35

XBI vs. FLIN - Sectors Allocation Comparison

Sectors	XBI	FLIN
Healthcare	99.8%	6.5%
Financial Services	0.2%	27.2%
Basic Materials	0.2%	9.2%
Communication Services	-	4.6%
Consumer Cyclical	-	12.0%
Consumer Defensive	-	5.8%
Energy	-	9.5%
Industrials	-	10.3%
Real Estate	-	1.3%
Technology	-	8.4%
Utilities	-	5.3%

Return for Risk

XBI vs. FLIN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XBI

XBI Risk / Return Rank: 85
XBI Sharpe Ratio Rank: 83
XBI Sortino Ratio Rank: 82
XBI Omega Ratio Rank: 74
XBI Calmar Ratio Rank: 94
XBI Martin Ratio Rank: 90

FLIN

FLIN Risk / Return Rank: 3
FLIN Sharpe Ratio Rank: 3
FLIN Sortino Ratio Rank: 3
FLIN Omega Ratio Rank: 3
FLIN Calmar Ratio Rank: 4
FLIN Martin Ratio Rank: 0

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XBI vs. FLIN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and Franklin FTSE India ETF (FLIN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	XBI	FLIN	Difference
Sharpe ratio: Return per unit of total volatility	2.23	-0.88	+3.11
Sortino ratio: Return per unit of downside risk	3.06	-1.22	+4.27
Omega ratio: Gain probability vs. loss probability	1.36	0.86	+0.50
Calmar ratio: Return relative to maximum drawdown	5.99	-0.71	+6.69
Martin ratio: Return relative to average drawdown	17.65	-1.68	+19.33

XBI vs. FLIN - Sharpe Ratio Comparison

The current XBI Sharpe Ratio is 2.23, which is higher than the FLIN Sharpe Ratio of -0.88. The chart below compares the historical Sharpe Ratios of XBI and FLIN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

XBI vs. FLIN - Drawdown Comparison

The maximum XBI drawdown since its inception was -63.89%, which is greater than FLIN's maximum drawdown of -41.90%. Use the drawdown chart below to compare losses from any high point for XBI and FLIN.

Drawdown Indicators

	XBI	FLIN	Difference
Max Drawdown Largest peak-to-trough decline	-63.89%	-41.90%	-21.99%
Max Drawdown (1Y) Largest decline over 1 year	-9.72%	-18.79%	+9.07%
Max Drawdown (3Y) Largest decline over 3 years	-32.99%	-22.85%	-10.14%
Max Drawdown (5Y) Largest decline over 5 years	-54.71%	-22.85%	-31.86%
Max Drawdown (10Y) Largest decline over 10 years	-63.89%	—	—
Current Drawdown Current decline from peak	-23.28%	-18.31%	-4.97%
Average Drawdown Average peak-to-trough decline	-20.93%	-8.03%	-12.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.29%	7.89%	-4.60%

Volatility

XBI vs. FLIN - Volatility Comparison

SPDR S&P Biotech ETF (XBI) has a higher volatility of 10.38% compared to Franklin FTSE India ETF (FLIN) at 4.13%. This indicates that XBI's price experiences larger fluctuations and is considered to be riskier than FLIN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	XBI	FLIN	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.38%	4.13%	+6.25%
Volatility (6M) Calculated over the trailing 6-month period	20.76%	12.84%	+7.92%
Volatility (1Y) Calculated over the trailing 1-year period	26.12%	14.99%	+11.13%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	32.22%	15.76%	+16.46%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.01%	20.43%	+11.58%

XBI vs. FLIN - Expense Ratio Comparison

XBI has a 0.35% expense ratio, which is higher than FLIN's 0.19% expense ratio.

Dividends

XBI vs. FLIN - Dividend Comparison

XBI's dividend yield for the trailing twelve months is around 0.33%, less than FLIN's 0.63% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FLIN Franklin FTSE India ETF	0.63%	0.56%	1.58%	0.73%	0.73%	2.26%	0.68%	0.90%	0.92%	0.00%	0.00%	0.00%
XBI SPDR S&P Biotech ETF	0.33%	0.37%	0.15%	0.02%	0.00%	0.04%	0.20%	0.00%	0.28%	0.24%	0.26%	0.61%

Frequently Asked Questions

Can I hold both XBI and FLIN in my portfolio?

XBI and FLIN have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, XBI or FLIN?

XBI has higher volatility (10.38%) compared to FLIN (4.13%). In terms of maximum drawdown, XBI dropped -63.89% vs FLIN's -41.90%.

Which ETF is better, XBI or FLIN?

On 5-year performance, FLIN leads with 3.66% vs -0.35% for XBI. On fees, FLIN is cheaper at 0.19% per year. On volatility, FLIN has been the lower-risk option at 4.13%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, XBI or FLIN?

Over the 5-year period, FLIN has performed better with a 3.66% return vs -0.35%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, XBI or FLIN?

FLIN is cheaper with a 0.19% expense ratio, compared with 0.35% for XBI.

Which ETF pays a higher dividend yield, XBI or FLIN?

FLIN has the higher dividend yield at 0.63%, compared with 0.33% for XBI.

What is the main difference between XBI and FLIN?

XBI is categorized as Health & Biotech Equities, while FLIN is Asia Pacific Equities. XBI tracks S&P Biotechnology Select Industry Index, while FLIN tracks FTSE India RIC Capped Index. They also come from different issuers: State Street and Franklin Templeton. Their fees differ too: 0.35% for XBI and 0.19% for FLIN.

Which has better risk-adjusted returns?

XBI currently has the higher Sharpe Ratio (2.23 vs -0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.